跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
miRNA-29
首页
药物
miRNA-29
miRNA-29
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Antagonists of miRNA-29 expression and their use in the prevention and treatment of aneurysm
US 9062307 B2
申请人: ZEIHER ANDREAS
优先权: 2010
CN
EP
US
4 件公开
BIOMARKER FOR DIAGNOSING NONALCOHOLIC STEATOHEPATITIS USING MICRORNA COMBINATION
US 20250011867 A1
申请人: UNIV KOREA RES & BUS FOUND
优先权: 2020
CN
US
2 件公开
MicroRNA (miRNA) for the diagnosis and treatment of heart diseases
EP 2489742 A1
申请人: UNIV WUERZBURG J MAXIMILIANS
优先权: 2007
EP
miR-29模拟物及其用途
CN 107108685 B
申请人: 米拉根医疗股份有限公司
优先权: 2014
CN
Methods for enhancing or decreasing the levels of MIR124 and MIR29 in subjects with muscular dystrophy
US 10119140 B2
申请人: BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIV OF NEVADA
优先权: 2015
US
Method for inhibiting gastric cancer angiogenesis by using micro vesicles as miRNA (Micro Ribonucleic Acid) transport carriers
CN 107422108 A
申请人: TIANJIN CANCER HOSPITAL
优先权: 2017
CN
Mesenchymal stem cell exosome for overexpressing miR-29 and application of mesenchymal stem cell exosome
CN 121852476 A
申请人: SHANDONG SECOND MEDICAL UNIV
优先权: 2026
CN
药物
反馈